How to buy Tenaya Therapeutics stock
Learn how to easily invest in Tenaya Therapeutics stock.
Tenaya Therapeutics is a biotechnology business based in the US. Tenaya Therapeutics shares (TNYA) are listed on the NASDAQ and all prices are listed in US Dollars. Tenaya Therapeutics employs 141 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Tenaya Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – TNYA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Tenaya Therapeutics stock price (NASDAQ: TNYA)Use our graph to track the performance of TNYA stocks over time.
Tenaya Therapeutics shares at a glance
|Latest market close||$2.83|
|52-week range||$1.64 - $8.09|
|50-day moving average||$4.82|
|200-day moving average||$4.07|
|Wall St. target price||$21.33|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.15|
Buy Tenaya Therapeutics stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Tenaya Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Tenaya Therapeutics price performance over time
|1 week (2023-09-15)||-11.84%|
|1 month (2023-08-24)||-33.25%|
|3 months (2023-06-23)||-50.70%|
|6 months (2023-03-24)||11.86%|
|1 year (2022-09-23)||-11.01%|
|2 years (2021-09-24)||-84.95%|
|3 years (2020-09-20)||N/A|
|5 years (2018-09-20)||N/A|
Tenaya Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-35.32%|
|Return on equity TTM||-62.45%|
|Market Capitalization||$255.2 million|
TTM: trailing 12 months
Tenaya Therapeutics share dividends
We're not expecting Tenaya Therapeutics to pay a dividend over the next 12 months.
Tenaya Therapeutics share price volatility
Over the last 12 months, Tenaya Therapeutics's shares have ranged in value from as little as $1.64 up to $8.0914. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tenaya Therapeutics's is 2.0513. This would suggest that Tenaya Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
To put Tenaya Therapeutics's beta into context you can compare it against those of similar companies.
- Verve Therapeutics (VERV.US): 1.6072
- Boston Scientific (BSX.US): 0.7759
- Cardiovascular Systems (CSII.US): 0.737
Tenaya Therapeutics overview
Tenaya Therapeutics, Inc. , a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy; TN-301, a small molecule for heart failure with preserved ejection fraction; and TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy. It also develops an adeno-associated virus-based gene therapy designed to deliver the dwarf open reading frame gene in the heart for dilated cardiomyopathy; and reprogramming program for cardiac regeneration to replace heart cells lost in patients experiencing heart failure due to prior myocardial infarction. The company was incorporated in 2016 and is headquartered in South San Francisco, California. .
Tenaya Therapeutics in the news
Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences
Tenaya Therapeutics to Participate at the 21st Annual Morgan Stanley Global Healthcare Conference
Frequently asked questionsWhat percentage of Tenaya Therapeutics is owned by insiders or institutions?
Currently 4.618% of Tenaya Therapeutics shares are held by insiders and 67.98% by institutions. How many people work for Tenaya Therapeutics?
Latest data suggests 141 work at Tenaya Therapeutics. When does the fiscal year end for Tenaya Therapeutics?
Tenaya Therapeutics's fiscal year ends in December. Where is Tenaya Therapeutics based?
Tenaya Therapeutics's address is: 171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is Tenaya Therapeutics's ISIN number?
Tenaya Therapeutics's international securities identification number is: US87990A1060
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert